Functional Brain Imaging in Healthy Volunteers and Neurological Patients to study Cognitive Functions
The purpose of this protocol is to learn about scale-free brain activity as well as conscious vs. unconscious processing in the brain. To improve such knowledge, we will conduct small pilot substudies using non-invasive methodologies to study the healthy human brain, all with minimal risks. This research is expected to help develop techniques and hypotheses for future research on these topics.
Gamma Knife Radiosurgery | NYU Langone Health
Physicians at NYU Langone’s Center for Advanced Radiosurgery are experts in Gamma Knife treatment for neurological conditions.
Gamma Knife Radiosurgery for Glioma & Astrocytoma | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center may use noninvasive Gamma Knife® radiosurgery to manage gliomas and astrocytomas.
Gamma Knife Radiosurgery for Metastatic Brain Tumors | NYU Langone Health
NYU Langone physicians may use Gamma Knife radiosurgery to manage metastatic brain tumors that can’t be surgically removed.
Ganglion Cysts | NYU Langone Health
NYU Langone specialists offer several treatment options for ganglion cysts, noncancerous lumps that develop on the wrist or hand.
Gastroenterology Research & Clinical Trials | NYU Langone Health
NYU Langone Long Island Clinical Research Associates offers opportunities to participate in clinical trials and research studies.
Gastroesophageal Reflux Disease | NYU Langone Health
NYU Langone specialists care for patients with gastroesophageal reflux disease, or GERD, using advanced diagnostic technologies and treatments.
Gastrointestinal & Liver Conditions | NYU Langone Health
NYU Langone specialists provide the most advanced preventive, diagnostic, and treatment options for gastrointestinal and liver conditions.
Gaucher Disease Outcome Survey (GOS)
The Gaucher Outcome Survey (GOS) is a long term observational survey. This survey aims to collect as much information as possible from as many Gaucher disease patients about the course of their disease, their medical management & the use of current or past medications or treatments, if any. Patient participation in GOS will be voluntary & GOS will be open to patients with Gaucher disease of any phenotype. Patients who are naïve to treatment, patients who are currently or have been previously treated with VPRIV, as well as patients who have been exposed to or are currently receiving other treatments for Gaucher disease may be included. This study is designed to gain a better understanding of the clinical course of the disease and its response to VPRIV therapy, thereby improving the clinical management of patients affected by Gaucher disease.
GBM AGILE TRIAL
Glioblastoma adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/III response adaptive randomization platform trial designed to evaluate multiple therapies in newly diagnosed (ND) and recurrent GBM. Its goals are to identify effective therapies for glioblastoma and match effective therapies with patient subtypes. Bayesian response adaptive randomization is used within subtypes of the disease to assign participants to Arms based on their performance. The primary endpoint is overall survival (OS).